Vital Signs: Daily Pill Can Prevent HIV Infographics

Reaching people who could benefit from PrEP

Updated Nov. 24, 2015

A focused effort by New York State to increase PrEP uptake started in June, 2014 and included:

Number of New York State Medicate beneficiaries receiving PrEP. 2012-2013: 259. 2013-2014:303. 2014-2015:1,330.

SOURCE: NYS Medicaid Data Warehouse (based on Medicaid data loaded through July 2015)

Test for HIV including acute infection.
- If HIV positive, provide or refer patient for HIV treatment and other services to maintain health and prevent further spread of HIV.
- If HIV negative, ask about sex and drug use behaviors.
- If HIV risk is low, discuss prevention methods.
- If HIV risk is high, discuss risk behaviors, PrEP, and use of other prevention methods.

Order recommended tests if patient is interested in PrEP and could benefit from it.
- If tests show reason not to prescribe PrEP (e.g. abnormal kidney function), discuss other prevention methods.
- If tests show patient still benefits from taking PrEP, go to Step 3.

Help patient apply for insurance or other programs to pay for PrEP.
- Most public and private insurance programs cover PrEP, and patients can get help with their co-payments.
- Drug assistance programs can help patients without insurance pay for PrEP.

Prescribe
- PrEP and instruct patient to take one pill every day.
  Currently Truvada®* is the only medicine approved by the FDA for PrEP.
  *Tenofovir disoproxil fumarate/emtricitabine

Follow-up
- Schedule appointments every 3 months for follow-up, including HIV testing and prescription refills.

PrEP Clinician Helpline: (855) 448-7737 or (855) HIV-PrEP
2014 PrEP Clinical Practice Guidelines [867KB]

SOURCE: 2014 PrEP Clinical Practice Guidelines